[Disclosure] Hanamicron(067310) Announces Concurrent Paid-in(5M shares) and Bonus Issue Strategy

Fact Source: Financial Supervisory Service – Data Analysis, Retrieval and Transfer System (DART) / 2024-05-17

Disclosure Type: Decision on Paid-in and Bonus Issue (Shareholder Allocation with Public Offering)

💡 3-Second Summary Hanamicron plans to raise approximately 112.5 billion KRW through a paid-in capital increase for facility and operational funding, followed by a bonus issue (0.15 shares per 1 existing share) to reward shareholders.

📊 1. [Key Details and Figures]

• Paid-in Issue Size: 5,000,000 common shares (Expected price: 22,500 KRW)
• Purpose of Funds: Facility investment (68.7B KRW), Debt repayment (25B KRW), Operational expenses (18.8B KRW)
• Method: Shareholder allocation followed by a public offering of forfeited shares.
• Bonus Issue Ratio: 0.15 shares per existing share (Record date: Aug 9, 2024)
• Key Dates: Paid-in record date (Jun 20), Payment date (Aug 6), Listing date (Aug 20)

📈 2. [Expert Insight: Impact Analysis on Stock Price]

This decision is viewed as a move to secure growth capital for facility expansion while balancing the impact on existing shareholders through a bonus issue. While the large-scale rights offering may impose temporary pressure on the stock price due to dilution concerns, the allocation of funds toward facility expansion in a recovering semiconductor market could enhance the company’s long-term fundamentals. Investors should closely monitor the subscription rates and the trading activity of the rights certificates to gauge market sentiment regarding this capital structure adjustment.

📝 Editor’s Comment (by K-STOCK Editor)

Hanamicron is taking a classic capital strategy move, pairing the ‘bitter medicine’ of a rights offering with the ‘sweet reward’ of a bonus issue to support aggressive facility investment. The focus should not just be on the issuance volume, but on whether the 68.7 billion KRW earmarked for facilities will effectively translate into increased productivity and long-term enterprise value during the industry’s recovery cycle.

📢 Disclaimer Source: This content is structured and written based on official data submitted to the Financial Supervisory Service’s DART system. Investment Risk Notice: This content is provided for informational and reference purposes only. It does not constitute financial advice or a recommendation to buy or sell any stock. All investment decisions and financial responsibilities rest solely with the investor. Inquiry: For compliance or copyright-related matters, please contact ksb220805@gmail.com